Globus Medical Inc.
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.94B | $2.52B | $1.57B | $1.02B | $958.1M | $789.0M | $785.4M | $713.0M |
| Cost of Revenue | $957.8M | $1.04B | $548.2M | $263.7M | $239.2M | $217.5M | $180.0M | $159.4M |
| Gross Profit | $1.98B | $1.48B | $1.02B | $759.1M | $718.9M | $571.6M | $605.4M | $553.6M |
| Gross Margin | 67.4% | 58.9% | 65.1% | 74.2% | 75.0% | 72.4% | 77.1% | 77.6% |
| Operating Expenses | ||||||||
| Research & Development | $147.2M | $163.8M | $124.0M | $73.0M | $97.3M | $84.5M | $60.1M | $55.5M |
| SG&A Expense | $1.18B | $981.4M | $643.8M | $432.1M | $408.1M | $354.8M | $354.8M | $311.6M |
| Operating Income | $479.8M | $166.0M | $133.1M | $228.0M | $172.0M | $111.4M | $172.0M | $169.3M |
| Operating Margin | 16.3% | 6.6% | 8.5% | 22.3% | 17.9% | 14.1% | 21.9% | 23.7% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | $605.1M | $120.7M | $165.4M | $243.0M | $180.4M | $125.9M | $189.9M | $188.6M |
| Income Tax Expense | $67.2M | $17.7M | $42.5M | $52.9M | $31.2M | $23.6M | $34.7M | $32.1M |
| Net Income | $537.9M | $103.0M | $122.9M | $190.2M | $149.2M | $102.3M | $155.2M | $156.5M |
| Net Margin | 18.3% | 4.1% | 7.8% | 18.6% | 15.6% | 13.0% | 19.8% | 21.9% |
| EPS (Basic) | $3.98 | $0.76 | $1.09 | $1.89 | $1.48 | $1.04 | $1.57 | $1.60 |
| EPS (Diluted) | $3.92 | $0.75 | $1.07 | $1.85 | $1.44 | $1.01 | $1.52 | $1.54 |
| Shares Outstanding (Basic) | 135.2M | 135.7M | 113.1M | 100.5M | 100.7M | 98.6M | 99.2M | 97.9M |
| Shares Outstanding (Diluted) | 137.1M | 137.9M | 114.6M | 102.6M | 103.6M | 101.0M | 102.0M | 101.3M |
| Dividends Per Share | — | — | — | — | — | — | — | — |